
Join to View Full Profile
10710 Charter DriveSuite 400Columbia, MD 21044
Phone+1 410-997-7979
Fax+1 410-997-9231
Dr. Farb is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Andrew Farb, MD is the Chief Medical Officer in the Office of Cardiovascular Devices at FDA’s Center for Devices and Radiological Health (CDRH). He has research interests and publications on coronary atherosclerosis and mechanisms of thrombosis, coronary artery interventions, and structural heart disease. Dr. Farb joined the FDA in 2004. In addition to his cardiovascular devices chief medical officer duties, he works on medical device innovation and facilitating the performance of early-stage medical device studies in the US. He also engages in patient care as an attending physician in clinical cardiology at the Johns Hopkins Howard County Medical Center in Columbia, MD. His education includes a fellowship in Cardiovascular Disease and residencies in Internal Medicine and Anatomic Pathology at the New York Presbyterian Hospital (Cornell Campus). He is board-certified in cardiovascular diseases and is a Fellow in the American College of Cardiology.
Education & Training
Armed Forces Institute of PathologyFellowship, Cardiovascular Disease, 1989 - 1991
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 1987 - 1988
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1986 - 1987
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1983 - 1986
Weill Cornell MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1984 - Present
MD State Medical License 1989 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification GEMMS ONE, GEMMS, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification GEMMS ONE, GEMMS, 2012-2014, 2016-2017
- Top Doctors:Washington DC Area Castle Connolly, 2012
Publications & Presentations
PubMed
- 5 citationsPatient-Reported Outcomes as End Points in Heart Failure Trials.Javed Butler, Muhammad Shariq Usman, Charu Gandotra, Ali Salman, Andrew Farb
Circulation. 2025-04-15 - An Innovative Program for Evidence Generation: HFC Perspective on the FDA Total Product Life Cycle Advisory Program.Mona Fiuzat, Kimberly Ferlin, Laura Gottschalk, Andrew Farb, Isabella Cavagna
JACC. Heart Failure. 2025-04-01 - 17 citationsPostmarketing Surveillance of Inferior Vena Cava Filters Among US Medicare Beneficiaries: The SAFE-IVC Study.Enrico G Ferro, Julie B Mackel, Renee D Kramer, Rebecca Torguson, Eleni M Whatley
JAMA. 2024-12-24
Journal Articles
- The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular DevicesAaron Kaplan, Martin Leon, Michael J Mack, Andrew Farb, ScienceDirect
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
acc/aha Clinical Data StandardsNovember 12th, 2014
Women and Minorities Underrepresented in Heart Valve TrialsAugust 1st, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









